Home | Health News | Themes | Search | Blog | Testimonials | Blood Bank | About Us
 
   
   
   
   
   
   
   
 
testing

 
   
BIO-D3  CALCIBEST  CALOSTO  CALTROL  OSTRIOL  ROCALTROL  ROLSICAL 
 



Indication & Dosage
 
 
Oral
VITAMIN D-RESISTANT RICKETS (FAMILIAL HYPOPHOSPHATAEMIA)
Child: 0.015-0.02 mcg/kg once daily. Maintenance: 0.03-0.06 mcg/kg once daily. Max: 2 mcg once daily
 
Oral
VITAMIN D-RESISTANT RICKETS (FAMILIAL HYPOPHOSPHATAEMIA)
Adult: 0.015-0.02 mcg/kg once daily. Maintenance: 0.03-0.06 mcg/kg once daily. Max: 2 mcg once daily.
 
Oral
HYPOPARATHYROIDISM/PSEUDOHYPOPARATHYROIDISM
Child: 1-5 yr: 0.25-0.75 mcg once daily; >6 yr: 0.5-2 mcg once daily.
 
Oral
HYPOPARATHYROIDISM/PSEUDOHYPOPARATHYROIDISMIN RENAL FAILURE
Adult: 0.5-2 mcg once daily.
 
Oral
HYPERPARATHYROIDISM IN RENAL FAILURE
Child: 0.25-2 mcg daily with haemodialysis
 
Oral
HYPERPARATHYROIDISM IN RENAL FAILURE
Adult:  0.25 mcg daily or every other day. May increase by 0.25 mcg daily at intervals of 4-8 wk.
 
Oral
HYPOCALCAEMIA IN PREMATURE INFANTS
Child: 1 mg once daily for 5 days
 
Intravenous
HYPERPARAYTHYROIDISM IN DIALYSIS PATIENTS
Adult: 0.5-4 mcg 3 times/wk, increased if needed in steps of 0.25-0.5 mcg at intervals of 2–4 wk; max. 8 mcg 3 times/wk
 
Intravenous
HYPERPARAYTHYROIDISM IN DIALYSIS PATIENTSIN RENAL FAILURE
Child: 1 mcg once daily.
 
Intravenous
HYPERPARATHYROIDISM IN RENAL FAILURE
Adult:  0.5 mcg daily 3 times/wk if undergoing haemodialysis. If necessary, dose can be increased by 0.25-0.5 mcg at intervals of 2-4 wk. Maintenance: 0.5-3 mcg 3 times/wk.
 
Intravenous
HYPOCALCAEMIC TETANY IN PREMATURE INFANTS
Child: 0.05 mcg/kg once daily for 5-12 days.
   
Administration May be taken with or without food. (May be taken w/ meals to reduce GI discomfort.)
   
Precautions Idiopathic hypercalcaemia. Pediatric doses must be individualised and monitored under close medical supervision. Coronary disease, renal function impairment and arteriosclerosis, especially in the elderly. Hypoparathyroidism.
   
Adverse Drug Reactions Weakness; headache; somnolence; nausea; vomiting; dry mouth; constipation; muscle pain; bone pain; metallic taste; polyuria; polydipsia; anorexia; irritability; weight loss; nocturia; mild acidosis; reversible azotemia; generalized vascular calcification; nephrocalcinosis; conjunctivitis (calcific); pancreatitis; photophobia; rhinorrhoea; pruritus; hyperthermia; decreased libido; elevated BUN; albuminuria; hypercholesterolaemia; elevated AST and ALT; ectopic calcification; hypertension; cardiac arrhythmias.
   
Interactions Hypermagnesaemia may develop in patients on chronic renal dialysis. Hypercalcaemia in patients on digitalis may precipitate cardiac arrhythmias. Intestinal absorption of calcitriol may be reduced by cholestyramine and colestipol. Phenytoin, barbiturates may decrease the T½ of calcitriol. May develop hypercalcaemia with thiazide diuretics.
   
   
 

 

SocialTwist Tell-a-Friend
 
 
Home  |   Privacy Policy   |   News Lettter   |   Site Map   |  Disclaimer  |  About Us
   copyright@totalhealthneeds.com   Webmaster:- o3sa.co.in